The implication of GRP in pathophysiology is far from new; both GRP analogues and GRP receptor antagonists are important targets in anti-cancer therapies already58, 59 and both have been proposed as putative targets in neuropsychiatric disorders60, 61, 62. The gene discussed is GRP; the disease is cancer.